On Friday, 20 October 2017, Brazil delivered the following statement during TRIPS Council discussions on compulsory licensing. Brazil zeroed in a recent compulsory licensing case in Germany involving raltagravir, an antiretroviral.
On 20 October 2017, South Africa delivered the following statement on behalf of Brazil, China, India, and South Africa during the WTO TRIPS Council’s discussions on compulsory licensing. On 31 May 2017, these delegations (along with Fiji) submitted a proposal to the TRIPS Council on “Intellectual Property and the Public Interest” which would serve as an overarching theme for the Council to address issues including access to knowledge and access to medicines. Continue Reading